Nanobiotix S.A. (NBTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 940.97M |
| Enterprise Value | 983.54M |
| P/E Ratio | -26.38 |
| PEG Ratio | 0.21 |
| Price/Sales Ratio | 172.8 |
| Price/Book Ratio | -42.5 |
| Enterprise/Revenue | 172.3 |
| Enterprise/EBITDA | -45.21 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -6.18 |
| Operating Margin | -3.68 |
AD
Management Effectiveness
| Return On Assets | -0.41 |
| Return On Equity | 0.9 |
Income Statement
| Revenue | 29.64M |
| Revenue/Share | 0.18 |
| Gross Profit | 29.64M |
| EBITDA | -12.07M |
| Net Income | -23.96M |
| Diluted EPS | -0.5 |
Balance Sheet
| Total Cash | 110.85M |
| Total Cash/Share | 2.27 |
| Total Debt | 106.57M |
| Total Debt/Equity | -3.19 |
| Current Ratio | 1.44 |
| Book Value Per Share | -0.68 |
Price History
| 52-Week Change | 57.12 |
| 52-Week High | 57.14 |
| 52-Week Low | 19.14 |
| Moving Average 50 Days | 31 |
| Moving Average 200 Days | 34.11 |
Statistics
| Average Volume | 159,873 |
| Shares Outstanding | 46.97M |
| % Held by Institutions | 12.11 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
